Most patients receiving chemotherapy with taxanes or platinum salts develop pain and loss of sensitivity in their hands and feet—a severe side effect that can interfere with proper treatment. Addressing this unmet clinical need, researchers at the Institute of Research, Development and Innovation in Health Biotechnology of Elche (IDiBE) at Miguel Hernández University (UMH) have coordinated an international clinical trial demonstrating the effectiveness of an innovative topical cream developed at UMH to relieve these symptoms and improve cancer patients’ quality of life.
This article was originally published on MedicalXpress.com
